Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Leukemia, Promyelocytic, Acute 3Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Precancerous Conditions 1Neoplasms 1Leukemia 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Colposcopy 17Methods 14Early Intervention, Educational 12Cisplatin 12Brachytherapy 11Human Papillomavirus DNA Tests 10Blood Specimen Collection 10Educational Status 9Biopsy 8Standard of Care 7Radiotherapy 7Patient Navigation 7Papanicolaou Test 7Magnetic Resonance Spectroscopy 7Vaginal Smears 6Sentinel Lymph Node Biopsy 6Mass Screening 6Counseling 6Acetic Acid 6Watchful Waiting 5Surveys and Questionnaires 5Radiotherapy, Intensity-Modulated 5Therapeutics 4Specimen Handling 4Radiation Dose Hypofractionation 4Practice Guidelines as Topic 4Paclitaxel 4Transurethral Resection of Prostate 3Radiation 3Psychiatric Rehabilitation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Uterine Cervical Neoplasms × Tretinoin × Clear all
NCT00003598 2010-09-22

IRB 1996-0189

University of Michigan Rogel Cancer Center

Phase NA Completed
180 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡